KR101994175B1 - Method for producing red pepper paste using apple lactic acid bacteria fermented solution - Google Patents
Method for producing red pepper paste using apple lactic acid bacteria fermented solution Download PDFInfo
- Publication number
- KR101994175B1 KR101994175B1 KR1020180156593A KR20180156593A KR101994175B1 KR 101994175 B1 KR101994175 B1 KR 101994175B1 KR 1020180156593 A KR1020180156593 A KR 1020180156593A KR 20180156593 A KR20180156593 A KR 20180156593A KR 101994175 B1 KR101994175 B1 KR 101994175B1
- Authority
- KR
- South Korea
- Prior art keywords
- fermented
- fermentation
- apple
- lactic acid
- fermentation broth
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims abstract description 94
- 239000004310 lactic acid Substances 0.000 title claims abstract description 47
- 235000014655 lactic acid Nutrition 0.000 title claims abstract description 47
- 241000894006 Bacteria Species 0.000 title claims abstract description 45
- 240000004160 Capsicum annuum Species 0.000 title claims abstract description 19
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 title claims abstract description 19
- 235000007862 Capsicum baccatum Nutrition 0.000 title claims abstract description 19
- 239000001728 capsicum frutescens Substances 0.000 title claims abstract description 19
- 238000004519 manufacturing process Methods 0.000 title claims description 21
- 238000000855 fermentation Methods 0.000 claims abstract description 122
- 230000004151 fermentation Effects 0.000 claims abstract description 122
- 235000011430 Malus pumila Nutrition 0.000 claims abstract description 65
- 235000015103 Malus silvestris Nutrition 0.000 claims abstract description 65
- 241000186612 Lactobacillus sakei Species 0.000 claims abstract description 24
- 238000002156 mixing Methods 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 12
- 240000007594 Oryza sativa Species 0.000 claims abstract description 11
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 11
- 235000013312 flour Nutrition 0.000 claims abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 11
- 235000009566 rice Nutrition 0.000 claims abstract description 11
- 150000003839 salts Chemical class 0.000 claims abstract description 11
- 240000006439 Aspergillus oryzae Species 0.000 claims abstract description 10
- 235000002247 Aspergillus oryzae Nutrition 0.000 claims abstract description 10
- 241000209140 Triticum Species 0.000 claims abstract description 10
- 235000021307 Triticum Nutrition 0.000 claims abstract description 10
- 235000012907 honey Nutrition 0.000 claims abstract description 10
- 239000012141 concentrate Substances 0.000 claims abstract description 9
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 8
- 235000015197 apple juice Nutrition 0.000 claims description 23
- 229920002472 Starch Polymers 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 244000017020 Ipomoea batatas Species 0.000 claims description 2
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 3
- 239000000287 crude extract Substances 0.000 abstract description 2
- 241000220225 Malus Species 0.000 description 69
- 235000001014 amino acid Nutrition 0.000 description 21
- 229940024606 amino acid Drugs 0.000 description 21
- 150000001413 amino acids Chemical class 0.000 description 21
- 239000000523 sample Substances 0.000 description 17
- 239000000047 product Substances 0.000 description 15
- 235000000346 sugar Nutrition 0.000 description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 12
- 230000000840 anti-viral effect Effects 0.000 description 12
- 244000005700 microbiome Species 0.000 description 11
- 102000019280 Pancreatic lipases Human genes 0.000 description 10
- 108050006759 Pancreatic lipases Proteins 0.000 description 10
- 229940116369 pancreatic lipase Drugs 0.000 description 10
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 9
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 235000021016 apples Nutrition 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 8
- 150000007524 organic acids Chemical class 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 241000186660 Lactobacillus Species 0.000 description 7
- 229940039696 lactobacillus Drugs 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 235000008504 concentrate Nutrition 0.000 description 6
- 230000003247 decreasing effect Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 150000002989 phenols Chemical class 0.000 description 6
- 244000063299 Bacillus subtilis Species 0.000 description 5
- 235000014469 Bacillus subtilis Nutrition 0.000 description 5
- 235000002568 Capsicum frutescens Nutrition 0.000 description 5
- 230000002292 Radical scavenging effect Effects 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 241000193755 Bacillus cereus Species 0.000 description 4
- 240000008574 Capsicum frutescens Species 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 230000003579 anti-obesity Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000015140 cultured milk Nutrition 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 241000186675 Weissella confusa Species 0.000 description 3
- 235000010208 anthocyanin Nutrition 0.000 description 3
- 229930002877 anthocyanin Natural products 0.000 description 3
- 239000004410 anthocyanin Substances 0.000 description 3
- 150000004636 anthocyanins Chemical class 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000002906 microbiologic effect Effects 0.000 description 3
- 239000001814 pectin Substances 0.000 description 3
- 229920001277 pectin Polymers 0.000 description 3
- 235000010987 pectin Nutrition 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 235000013555 soy sauce Nutrition 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 235000019605 sweet taste sensations Nutrition 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- OYIFNHCXNCRBQI-UHFFFAOYSA-N 2-aminoadipic acid Chemical compound OC(=O)C(N)CCCC(O)=O OYIFNHCXNCRBQI-UHFFFAOYSA-N 0.000 description 2
- 240000001817 Cereus hexagonus Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010016952 Food poisoning Diseases 0.000 description 2
- 208000019331 Foodborne disease Diseases 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- 240000001929 Lactobacillus brevis Species 0.000 description 2
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 2
- 244000199866 Lactobacillus casei Species 0.000 description 2
- 235000013958 Lactobacillus casei Nutrition 0.000 description 2
- 241001134659 Lactobacillus curvatus Species 0.000 description 2
- 240000006024 Lactobacillus plantarum Species 0.000 description 2
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 241000192001 Pediococcus Species 0.000 description 2
- UYXTWWCETRIEDR-UHFFFAOYSA-N Tributyrin Chemical compound CCCC(=O)OCC(OC(=O)CCC)COC(=O)CCC UYXTWWCETRIEDR-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 241000384856 Weissella koreensis Species 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000021107 fermented food Nutrition 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000010794 food waste Substances 0.000 description 2
- 229960004279 formaldehyde Drugs 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 125000001475 halogen functional group Chemical group 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 229940017800 lactobacillus casei Drugs 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 235000019643 salty taste Nutrition 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- PKAUICCNAWQPAU-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)acetic acid;n-methylmethanamine Chemical compound CNC.CC1=CC(Cl)=CC=C1OCC(O)=O PKAUICCNAWQPAU-UHFFFAOYSA-N 0.000 description 1
- QWCKQJZIFLGMSD-UHFFFAOYSA-N 2-Aminobutanoic acid Natural products CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- QWCKQJZIFLGMSD-GSVOUGTGSA-N D-alpha-aminobutyric acid Chemical compound CC[C@@H](N)C(O)=O QWCKQJZIFLGMSD-GSVOUGTGSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 description 1
- 241001333951 Escherichia coli O157 Species 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000186779 Listeria monocytogenes Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 244000141359 Malus pumila Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- BZQFBWGGLXLEPQ-UHFFFAOYSA-N O-phosphoryl-L-serine Natural products OC(=O)C(N)COP(O)(O)=O BZQFBWGGLXLEPQ-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000209051 Saccharum Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- AVVATXXZVGFDQF-UHFFFAOYSA-N butanedioic acid 2-hydroxypropane-1,2,3-tricarboxylic acid oxalic acid Chemical compound C(CC(O)(C(=O)O)CC(=O)O)(=O)O.C(CCC(=O)O)(=O)O.C(C(=O)O)(=O)O AVVATXXZVGFDQF-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- -1 cellulosic Chemical compound 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000021403 cultural food Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229950006137 dexfosfoserine Drugs 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000021197 fiber intake Nutrition 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000019256 formaldehyde Nutrition 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 235000019534 high fructose corn syrup Nutrition 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000008991 intestinal motility Effects 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000012543 microbiological analysis Methods 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 description 1
- 229960001243 orlistat Drugs 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000011020 pilot scale process Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/70—Germinated pulse products, e.g. from soy bean sprouts
-
- A23L11/20—
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/10—Preserving against microbes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/179—Sakei
-
- A23Y2220/77—
Abstract
본 발명은 (1) 사과를 착즙한 착즙액에 락토바실러스 사케이(Lactobacillus sakei) 균주를 접종한 후 발효하여 사과 유산균 발효액을 제조하는 단계; (2) 상기 (1)단계의 제조한 사과 유산균 발효액에 찹쌀가루, 밀 종곡, 소금 및 아스퍼질러스 오리재 균주를 혼합한 후 1차 발효하는 단계; 및 (3) 상기 (2)단계의 1차 발효한 발효물에 고춧가루, 조청, 꿀, 매실 농축액 및 주정을 혼합한 후 2차 발효하는 단계를 포함하여 제조하는 것을 특징으로 하는 사과 유산균 발효액을 이용한 고추장의 제조방법 및 상기 방법으로 제조된 사과 유산균 발효액을 이용한 고추장에 관한 것이다.(1) a step of inoculating Lactobacillus sakei strain into a juice obtained by juicing an apple and fermenting the Lactobacillus sakei strain to produce a fermentation broth of an apple lactic acid bacterium; (2) a step of mixing the glutinous rice flour, wheat germ, salt and Aspergillus oryzae strain fermented by the fermentation broth of the fermented fermented lactic acid bacteria prepared in the step (1), followed by primary fermentation; And (3) a step of fermenting the fermented product of the first fermentation in the step (2) by mixing the red pepper powder, the crude extract, the honey, the plum concentrate and the alcohol, and then performing the second fermentation. The present invention relates to a process for producing kochujang, and a kochujang using the fermentation broth of the fermented lactic acid fermented by the method.
Description
본 발명은 사과를 착즙한 착즙액에 락토바실러스 사케이(Lactobacillus sakei) 균주를 접종한 후 발효한 사과 유산균 발효액을 이용한 고추장의 제조방법 및 상기 방법으로 제조된 사과 유산균 발효액을 이용한 고추장에 관한 것이다.The present invention relates to a method for producing a kochujang using an fermented broth of fermented apple fermented broth after inoculation with a lactic acid bacteria fermented with an Lactobacillus sakei strain and a fermented broth of fermented apple fermented lactic acid produced by the fermented broth.
사과는 장미과 Malus속에 속하는 다년생 식물인 사과나무의 열매로, 단백질과 지방은 비교적 적으며, 비타민 A, 비타민 C, 무기염류의 함량이 높은 알칼리성 과실이다.Apples are fruit of apple tree which is a perennial plant belonging to rose and Malus genus. It is relatively low in protein and fat, and high in content of vitamin A, vitamin C and inorganic salts.
사과의 식물섬유에는 혈액의 콜레스테롤과 혈당을 낮추는 작용을 하는 펙틴과 대변 작용을 원활하게 하는 셀룰로오스, 리그닌, 헤미셀룰로오스 등 유익한 섬유소가 포함되어 있다. 사과에 포함되어 있는 수용성 식이섬유인 펙틴은 위액의 점도를 높이기 때문에 체류시간이 길어져 위에서의 음식물 배출이 늦어지고, 소장에서 당분의 흡수가 지연되어 혈당의 급격한 상승이 억제되는 효능이 있다.Apple's plant fibers include pectin, which acts to lower blood cholesterol and blood sugar, and beneficial fibrin, such as cellulosic, lignin, and hemicelluloses, that facilitate stool action. Pectin, a soluble fiber contained in apples, increases the viscosity of gastric juices, so that the residence time is prolonged, delaying the discharge of food from the upper part, and delaying the absorption of sugar in the small intestine.
장 내에 들어간 사과의 식이섬유는 콜레스테롤, 담즙산, 나트륨, 유독물질 등을 흡착하여 다른 음식물 찌꺼기와 함께 대장으로 보내지게 되고, 대장 속에 섬유 섭취가 많으면 나쁜 세균이 감소되어 면역기능이 높아지며, 인체에 좋은 세균인 유산균 등에 의해 유기산이 생성되어 장운동이 활발해진다. 특히 장내에 식이섬유가 많으면 장의 운동성을 높여 음식찌꺼기의 장내 경과시간을 짧게 하여 변비 등을 예방하며 펙틴은 장내에서 갈락투론산을 분비시켜 간장에서의 지방산 합성을 억제하는 작용을 나타낸다.Apples in the intestines absorb cholesterol, bile acid, sodium, toxic substances, etc., and are sent to the large intestine with other food waste. When the fiber intake is large in the large intestine, bad bacteria are decreased and the immune function is enhanced. Organic acid is produced by bacteria such as lactic acid bacteria, and the intestinal motility becomes active. Especially, when there is a lot of dietary fiber in the intestines, the motility of the intestines is increased to shorten the time elapsed in the intestines of the food waste to prevent constipation and the like, and pectin secretes galacturonic acid in the intestines to inhibit the synthesis of fatty acids in the liver.
사과의 붉은색 과피에는 안토시아닌과 같은 폴리페놀계 항산화 물질이 포함되어 있으며, 안토시아닌은 혈액 중의 활성효소로부터의 피해를 방지하는 역할을 하므로, 사과를 과피 채 섭취하면 안토시아닌이 체내에 들어가 활성효소의 피해를 감소시킬 수 있다.The apple red skin contains polyphenolic antioxidants such as anthocyanins. Since anthocyanins prevent damage from active enzymes in the blood, anthocyanins enter the body when they eat apples and cause damage to active enzymes Can be reduced.
이와 같이 사과는 혈압강하 작용, 동맥경화 예방, 당뇨병 예방, 항산화 작용, 식이섬유에 의한 항암작용 및 비만 예방, 면역기능 증진에 효과가 뛰어날 뿐만 아니라, 건강과 피부미용에도 좋아 높은 소비량을 보이고 있다. 그러나, 저장성의 한계로 인하여 사과가 가지고 있는 신선한 향미를 장기간 보존하기가 어렵고, 계절적인 한계로 인하여 항상 섭취하기에는 불편한 점이 있다.As such, apples are effective for blood pressure lowering action, prevention of arteriosclerosis, prevention of diabetes, antioxidant activity, anti-cancer effect by dietary fiber, prevention of obesity and improvement of immune function, and also consumption is good for health and skin beauty. However, due to limitations of storage stability, it is difficult to preserve the fresh flavor of apples for a long time, and it is inconvenient to always eat due to seasonal limitations.
고추장은 간장, 된장과 예전부터 널리 애용되어 온 우리나라 고유의 전통 발효식품으로, 탄수화물에서 생성되는 당류의 단맛, 단백질에서 생성된 아미노산의 구수한 맛, 고춧가루의 매운맛, 그리고 소금의 짠맛 등이 잘 조화를 이루어 독특한 맛을 형성하는 복합 향신 조미료이다. 또한 된장과 간장에 비해 비타민 B1, B2, C 및 엽산(folic acid) 등이 다량 함유되어 있고, 미생물의 대사 및 발효작용으로 생성되는 유기산, 핵산, 알코올 및 색소 등의 미량성분이 맛, 향 및 색 등에 조화를 이루는 식품이다. 최근에는 소비자들의 식품 선택 시 식품의 관능적인 품질과 함께 기능성을 중시하는 경향으로 식생활 문화가 변화하고 있다. 그러한 변화를 반영하여 고추장에 다양한 식품을 첨가하여 풍미와 기능성을 동시에 향상시키려는 연구들이 보고되고 있다.Kochujang is a traditional fermented food of Korea that has been widely used for soy sauce, soybean paste, and soy sauce. It has a good balance of sweetness of carbohydrate, sweet taste of protein-produced amino acid, hot pepper powder and salty taste of salt. It is a complex spice seasoning that forms a unique taste. In addition, it contains a large amount of vitamin B1, B2, C and folic acid compared with soybean paste and soy sauce, and trace elements such as organic acid, nucleic acid, alcohol and pigment produced by metabolism and fermentation of microorganisms, It is food that harmonizes with color. Recently, the food culture of consumers is changing with the tendency to emphasize functionality along with sensual quality of food. Studies have been reported to improve flavor and functionality at the same time by adding various foods to kochujang reflecting such changes.
한국등록특허 제1489999호에는 아스퍼질러스 오리재 CJ 1354 균주를 이용한 쌀 고추장의 제조방법이 개시되어 있고, 한국등록특허 제0943070호에는 양파효소액을 이용한 인삼 고추장의 제조방법이 개시되어 있으나, 본 발명의 사과 유산균 발효액을 이용한 고추장의 제조방법과는 상이하다.Korean Patent No. 1489999 discloses a method for producing a rice kochujang using Aspergillus oryzae CJ-1354. Korean Patent Registration No. 0943070 discloses a method for producing ginseng kochujang using an onion enzyme solution. However, Of the present invention is different from the method of producing kochujang using the fermented broth of fermented broth.
본 발명은 상기와 같은 요구에 의해 안출된 것으로서, 본 발명의 목적은 바실러스 세레우스 억제능이 우수하고, 아미노태 질소, 유리 아미노산 및 총 페놀 함량이 높고, 항산화 활성 및 항비만 활성과 같은 기능성과 기호도가 우수한 사과 발효액을 이용한 고추장을 제조하기 위해, 사과 발효액 제조에 적합한 균주 선정, 부재료 종류 및 배합비와 발효 조건 등의 제조조건을 최적화하여 품질 및 기호도가 우수한 고추장의 제조방법을 제공하는 데 있다.The present invention has been made in view of the above-mentioned needs, and an object of the present invention is to provide a pharmaceutical composition which is excellent in inhibiting Bacillus cereus, has high amino acid nitrogen, free amino acid and total phenol content, The present invention is to provide a method of manufacturing a kochujang having excellent quality and favorability by optimizing manufacturing conditions such as selection of a strain suitable for manufacturing an apple fermentation broth, kinds of materials and compounding ratio, and fermentation conditions.
상기 과제를 해결하기 위해, 본 발명은 (1) 사과를 착즙한 착즙액에 락토바실러스 사케이(Lactobacillus sakei) 균주를 접종한 후 발효하여 사과 유산균 발효액을 제조하는 단계; (2) 상기 (1)단계의 제조한 사과 유산균 발효액에 찹쌀가루, 밀 종곡, 소금 및 아스퍼질러스 오리재 균주를 혼합한 후 1차 발효하는 단계; 및 (3) 상기 (2)단계의 1차 발효한 발효물에 고춧가루, 조청, 꿀, 매실 농축액 및 주정을 혼합한 후 2차 발효하는 단계를 포함하여 제조하는 것을 특징으로 하는 사과 유산균 발효액을 이용한 고추장의 제조방법을 제공한다.In order to solve the above-mentioned problems, the present invention provides a method for producing a fermented apple lactic acid bacterium, comprising the steps of: (1) preparing a fermented broth of an apple lactic acid bacterium by inoculating Lactobacillus sakei strain into an apple juice; (2) a step of mixing the glutinous rice flour, wheat germ, salt and Aspergillus oryzae strain fermented by the fermentation broth of the fermented fermented lactic acid bacteria prepared in the step (1), followed by primary fermentation; And (3) a step of fermenting the fermented product of the first fermentation in the step (2) by mixing the red pepper powder, the crude extract, the honey, the plum concentrate and the alcohol, and then performing the second fermentation. A method of manufacturing a koji paste is provided.
또한, 본 발명은 상기 방법으로 제조된 사과 유산균 발효액을 이용한 고추장을 제공한다.The present invention also provides a red pepper paste using the fermentation broth of the fermented lactic acid fermented by the above method.
본 발명의 특정 락토바실러스 사케이(Lactobacillus sakei) SRCM101057 균주를 이용한 사과 유산균 발효액은 향미 및 맛이 우수하고, 상기 사과 유산균 발효액을 이용한 고추장은 유해 미생물에 대한 억제능이 우수할 뿐만 아니라, 아미노태 질소, 유리 아미노산 및 총 페놀 함량이 높고, 항산화 활성 및 항비만 활성과 같은 기능성과 기호도가 우수한 고추장을 제조할 수 있는 효과가 있다.The fermented broth of Lactobacillus sakei SRCM101057 according to the present invention is excellent in flavor and taste, and the koji paste using the fermented broth of the Lactobacillus sakei strain of the present invention is excellent in inhibiting harmful microorganisms, It is possible to produce a red pepper paste having high free amino acid content and total phenol content and excellent functionality and good taste such as antioxidant activity and anti-obesity activity.
본 발명의 목적을 달성하기 위하여, 본 발명은 In order to achieve the object of the present invention,
(1) 사과를 착즙한 착즙액에 락토바실러스 사케이(Lactobacillus sakei) 균주를 접종한 후 발효하여 사과 유산균 발효액을 제조하는 단계;(1) preparing a fermentation broth of an apple lactic acid bacterium by inoculating a juice obtained by inoculating an apple with a strain of Lactobacillus sakei , followed by fermentation;
(2) 상기 (1)단계의 제조한 사과 유산균 발효액에 찹쌀가루, 밀 종곡, 소금 및 아스퍼질러스 오리재 균주를 혼합한 후 1차 발효하는 단계; 및(2) a step of mixing the glutinous rice flour, wheat germ, salt and Aspergillus oryzae strain fermented by the fermentation broth of the fermented fermented lactic acid bacteria prepared in the step (1), followed by primary fermentation; And
(3) 상기 (2)단계의 1차 발효한 발효물에 고춧가루, 조청, 꿀, 매실 농축액 및 주정을 혼합한 후 2차 발효하는 단계를 포함하여 제조하는 것을 특징으로 하는 사과 유산균 발효액을 이용한 고추장의 제조방법을 제공한다.(3) mixing the fermented product of step (1) with the fermented product of step (2), and then fermenting the fermented product after mixing the red pepper powder, sweet potato, honey, Of the present invention.
본 발명의 고추장의 제조방법에서, 상기 (1)단계의 사과 유산균 발효액은 바람직하게는 사과를 착즙한 착즙액에 104~6 CFU/ml 농도의 락토바실러스 사케이(Lactobacillus sakei) 균주 0.8~1.2%(v/v)를 접종한 후 28~32℃에서 20~28시간 동안 발효하여 제조할 수 있으며, 더욱 바람직하게는 사과를 착즙한 착즙액에 105 CFU/ml 농도의 락토바실러스 사케이(Lactobacillus sakei) 균주 1%(v/v)를 접종한 후 30℃에서 24시간 동안 발효하여 제조할 수 있다. 상기와 같은 조건으로 발효하는 것이 발효취가 나지 않으면서 사과의 풍미 및 기능성을 더욱 향상시킬 수 있었다.In the method for manufacturing a kochujang of the present invention, the fermentation broth of the fermented apple fermentation broth of step (1) is preferably added to the juiced fermented broth in an amount of 10 4 to 6 CFU / ml of Lactobacillus sakei strain 0.8 to 1.2 (v / v) and then fermenting at 28 to 32 ° C for 20 to 28 hours. More preferably, the apple juice can be prepared by adding lactose to a solution of 10 5 CFU / ml Lactobacillus casei Lactobacillus sakei ) 1% (v / v) and then fermenting at 30 ° C for 24 hours. The fermentation under the above conditions enabled the flavor and functionality of the apples to be further improved without fermentation.
또한, 본 발명의 고추장의 제조방법에서, 상기 락토바실러스 사케이(Lactobacillus sakei) 균주는 락토바실러스 사케이(Lactobacillus sakei) SRCM101057 균주로, 한국미생물보존센터에 2017년 12월 08일자로 기탁하였다(기탁번호: KFCC11755P). 상기 기탁된 특정 균주는 항바이러스 활성 또는 면역증강 활성을 지니는 균주 중에서 사과와 적용 시 풍미 및 기호도를 증진시키고, 상기 균주를 이용한 사과 발효액을 고추장 제조에 사용할 경우 바실러스 세레우스와 같은 유해 미생물에 대한 억제능이 우수할 뿐만 아니라, 아미노태 질소, 유리 아미노산 및 총 페놀 함량이 높고, 항산화 활성 및 항비만 활성과 같은 기능성을 증진시키면서 기호도가 우수한 고추장 제조에 적합한 균주를 선발한 것이다.The Lactobacillus sakei strain of Lactobacillus sakei SRCM101057 was deposited at the Korean Microorganism Conservation Center on Dec. 08, 2017 in the method for producing kochujang of the present invention No. KFCC11755P). The above-mentioned specific strain promotes the flavor and the degree of preference when applied with apples among the strains having antiviral activity or immunity enhancing activity, and when the apple fermentation broth using the strain is used for the preparation of red pepper paste, the inhibitory effect on harmful microorganisms such as Bacillus cereus Which is high in amino acid nitrogen, free amino acid and total phenol content, and has improved functionality such as antioxidant activity and anti-obesity activity, and which is suitable for the production of kochujang having high palatability.
또한, 본 발명의 고추장의 제조방법에서, 상기 (3)단계의 매실 농축액은 바람직하게는 매실과 설탕을 0.8~1.2:0.8~1.2 중량비율로 혼합한 후 20~25℃에서 10~14개월 동안 발효하고 여과하여 제조할 수 있으며, 더욱 바람직하게는 매실과 설탕을 1:1 중량비율로 혼합한 후 20~25℃에서 12개월 동안 발효하고 여과하여 제조할 수 있다. 상기와 같이 제조된 매실 농축액을 고추장에 적정량 첨가할 경우 고추장의 텁텁한 맛을 잡아주면서 적절한 신맛과 단맛을 부여할 수 있다.In addition, in the method of manufacturing a kochujang of the present invention, the plum concentrate of the step (3) is preferably prepared by mixing plum and sugar at a ratio of 0.8-1.2: 0.8-1.2 weight, then stirring at 20-25 ° C for 10-14 months Fermentation and filtration, more preferably mixing 1: 1 weight ratio of plum and sugar, fermenting at 20 ~ 25 ° C for 12 months, and filtering. When an appropriate amount of the above-prepared mash concentrate is added to the kochujang, a proper sour taste and sweet taste can be imparted while keeping a strong taste of the kochujang.
본 발명의 사과 유산균 발효액을 이용한 고추장의 제조방법은, 보다 구체적으로는The method for producing the koji paste using the fermented broth of the fermented lactic acid bacteria of the present invention, more specifically,
(1) 사과를 착즙한 착즙액에 104~6 CFU/ml 농도의 락토바실러스 사케이(Lactobacillus sakei) SRCM101057 균주(기탁번호: KFCC11755P) 0.8~1.2%(v/v)를 접종한 후 28~32℃에서 20~28시간 동안 발효하여 사과 유산균 발효액을 제조하는 단계;(1) 0.8-1.2% (v / v) of Lactobacillus sakei SRCM101057 strain (accession number: KFCC11755P) at a concentration of 10 4 to 6 CFU / ml was inoculated into the apple juice juice, Fermenting at 32 ° C for 20 to 28 hours to prepare a fermentation broth of an apple lactic acid bacterium;
(2) 상기 (1)단계의 제조한 사과 유산균 발효액 220~280 g에 찹쌀가루 100~140 g, 밀 종곡 90~130 g, 소금 60~80 g 및 아스퍼질러스 오리재 균주 1~3 g을 혼합한 후 28~32℃에서 6~8일 동안 1차 발효하는 단계; 및(2) 100 to 140 g of glutinous rice flour, 90 to 130 g of wheat germ, 60 to 80 g of salt, and 1 to 3 g of Aspergillus oryzae strain were added to 220 to 280 g of the fermentation broth of the prepared fermented lactic acid bacterium of step (1) Followed by primary fermentation at 28-32 ° C for 6-8 days; And
(3) 상기 (2)단계의 1차 발효한 발효물에 고춧가루 170~200 g, 조청 180~220 g, 꿀 27~33 g, 매실 농축액 4~6 g 및 주정 27~33 g을 혼합한 후 28~32℃에서 6~8일 동안 2차 발효하는 단계를 포함할 수 있으며,(3) 170 to 200 g of red pepper powder, 180 to 220 g of starch, 27 to 33 g of honey, 4 to 6 g of a plum concentrate and 27 to 33 g of a fermented product were mixed with the first fermented fermented product of the step (2) Followed by secondary fermentation at 28-32 < 0 > C for 6-8 days,
더욱 구체적으로는More specifically,
(1) 사과를 착즙한 착즙액에 105 CFU/ml 농도의 락토바실러스 사케이(Lactobacillus sakei) SRCM101057 균주(기탁번호: KFCC11755P) 1%(v/v)를 접종한 후 30℃에서 24시간 동안 발효하여 사과 유산균 발효액을 제조하는 단계;(1) 1% (v / v) Lactobacillus sakei SRCM101057 strain (accession number: KFCC11755P) at a concentration of 10 5 CFU / ml was inoculated into the apple juice juice and incubated at 30 ° C for 24 hours Fermenting the fermentation broth of the fermented broth;
(2) 상기 (1)단계의 제조한 사과 유산균 발효액 248 g에 찹쌀가루 121 g, 밀 종곡 108 g, 소금 72 g 및 아스퍼질러스 오리재 균주 2 g을 혼합한 후 30℃에서 7일 동안 1차 발효하는 단계; 및(2) A mixture of 121 g of glutinous rice flour, 108 g of wheat germ, 72 g of salt, and 2 g of Aspergillus oryzae strain were mixed with 248 g of the fermentation broth of the prepared fermented lactic acid bacterium of step (1) A step of fermenting tea; And
(3) 상기 (2)단계의 1차 발효한 발효물에 고춧가루 185 g, 조청 200 g, 꿀 30 g, 매실 농축액 5 g 및 주정 30 g을 혼합한 후 30℃에서 7일 동안 2차 발효하는 단계를 포함할 수 있다.(3) 185 g of red pepper powder, 200 g of starch, 30 g of honey, 5 g of plum concentrate and 30 g of fermented milk were mixed with the fermented product of the first fermentation in the step (2), followed by secondary fermentation at 30 ° C for 7 days Step < / RTI >
본 발명의 고추장의 제조방법에서, 상기 (2) 및 (3)단계와 같은 조건으로 2단계에 걸쳐 발효하는 것이 이미 및 이취가 발생하지 않으면서 아미노태 질소 함량이 높아 품질이 우수한 고추장 제조에 적합한 조건으로 발효할 수 있었다.In the method for producing kochujang of the present invention, fermentation is carried out in two steps under the same conditions as in the above (2) and (3), since the content of amino nitrogen is high and no bad odor is generated, The conditions could be fermented.
또한, 본 발명의 고추장의 제조방법에서, 상기 (2) 및 (3)단계의 재료 및 배합비로 제조된 고추장은 재료들의 맛과 향이 잘 어우러져 고추장의 매운맛, 짠맛, 구수한 맛 및 감칠맛이 잘 조화되어 풍미가 우수하여 기호도를 향상시킬 수 있었다. 또한, 재료를 상기 (2) 및 (3)단계의 2단계에 걸쳐 배합함으로써 갈변에 의한 고추장 색상의 선호도 저하를 막을 수 있었다.In addition, in the method of manufacturing a kochujang of the present invention, the ingredients and the mixing ratio of the ingredients (2) and (3) produced in the kochujang mix well with the taste and flavor of the ingredients and thus the hot, salty, The flavor was excellent and the preference degree could be improved. Further, by mixing the ingredients in two steps of the above (2) and (3), it was possible to prevent a decrease in the preference of the color of kochujang due to browning.
본 발명은 또한, 상기 방법으로 제조된 사과 유산균 발효액을 이용한 고추장을 제공한다.
The present invention also provides a kochujang using the fermentation broth of the fermented lactic acid fermented by the above method.
이하, 본 발명의 제조예 및 실시예를 들어 상세히 설명한다. 단, 하기 제조예 및 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 제조예 및 실시예에 한정되는 것은 아니다.
Hereinafter, production examples and examples of the present invention will be described in detail. However, the following Preparation Examples and Examples are illustrative of the present invention, and the content of the present invention is not limited to the following Production Examples and Examples.
제조예Manufacturing example 1. 사과 유산균 발효액을 이용한 고추장 1. Red pepper paste
(1) 사과를 착즙한 착즙액에 기탁번호 KFCC11755P인 락토바실러스 사케이(Lactobacillus sakei) SRCM101057 균주(105 CFU/ml) 1%(v/v)를 접종한 후 30℃에서 24시간 동안 발효하여 사과 유산균 발효액을 제조하였다.(1) 1% (v / v) 1% (10 5 CFU / ml) of Lactobacillus sakei SRCM101057 strain with accession number KFCC11755P was inoculated into apple juice and fermented at 30 ° C for 24 hours The fermentation broth of apple lactic acid bacteria was prepared.
(2) 상기 (1)단계의 제조한 사과 유산균 발효액 248 g, 찹쌀가루 121 g, 밀 종곡 108 g, 천일염 72 g 및 아스퍼질러스 오리재 균주(105 CFU/ml) 2 g을 혼합한 후 30℃에서 7일 동안 1차 발효하였다.(2) After mixing 248 g of the fermented broth of the fermented lactic acid bacteria produced in the above step (1), 121 g of glutinous rice flour, 108 g of wheat germ, 72 g of salty flour and 2 g of Aspergillus oryzae strain (10 5 CFU / ml) Followed by primary fermentation at 30 ° C for 7 days.
(3) 상기 (2)단계의 1차 발효한 발효물에 고춧가루 185 g, 조청 200 g, 꿀 30 g, 매실엑기스 5 g 및 주정 30 g을 혼합한 후 30℃에서 7일 동안 2차 발효하고, 80℃에서 15분 동안 살균하였다.(3) 185 g of red pepper powder, 200 g of morning syrup, 30 g of honey, 5 g of plum extract and 30 g of fermented milk were mixed with fermented product of the first fermentation in the step (2), followed by secondary fermentation at 30 ° C for 7 days , And sterilized at 80 DEG C for 15 minutes.
1. 실험방법1. Experimental Method
1) 사과 발효액 제조 균주 목록1) List of strains that produce apple fermentation broth
본 실험에서는 사과 발효에 적합한 발효 균주를 선별하기 위해 사용한 균주는 하기 표 2와 같다. 다양한 GRAS 미생물인 고초균, 유산균 중에서 높은 항바이러스 활성 및 면역증강 활성을 지닌 균주를 사과와 적용하여 발효식품 적용가능성을 확인한 후 발효 균주로 사용하고자 하였다.In this experiment, strains used for selecting fermentation strains suitable for apple fermentation are shown in Table 2 below. Among the various GRAS microorganisms, Bacillus subtilis and Lactobacillus strains, which have high antiviral activity and immunity enhancing activity, were applied to apples and used as fermentation strains after confirming applicability of fermented foods.
2) 수분 함량2) Water content
수분함량은 적외선수분측정기(Kett, Japan)를 이용하여 측정하였다.
Moisture content was measured using an infrared moisture meter (Kett, Japan).
3) pH 및 적정 산도3) pH and titratable acidity
pH는 시료 5 g을 10배 희석하여 pH 미터(Mettler Toledo CH/MPC227, Switzerland)로 측정하였고, 적정 산도는 0.1N-NaOH를 가하여 pH 8.3이 될 때까지 적정하고, 이때 소비된 양을 mL 수로 표시하였다.
The pH was measured with a pH meter (Mettler Toledo CH / MPC227, Switzerland) diluted 10-fold with a 5-fold sample and the titratable acidity was titrated to pH 8.3 with 0.1 N NaOH, Respectively.
4) 아미노태 질소 함량4) Amino nitrogen content
아미노태 질소 함량은 Formol 적정법에 준하여 실시하였다. 즉, 시료 2 g을 취하여 증류수 100 mL를 가하고 1시간 동안 교반한 후 0.1N-NaOH 용액으로 pH 8.4까지 적정하였다. 여기에 중성 포르말린 용액 20 mL를 가하고 다시 0.1N-NaOH 용액으로 pH 8.4가 되도록 적정하였다.
Amino nitrogen content was determined according to the Formol titration method. That is, take 2 g of sample, add 100 mL of distilled water, stir for 1 hour, and titrate to pH 8.4 with 0.1 N NaOH solution. To this was added 20 mL of neutral formalin solution and titrated to pH 8.4 with 0.1 N NaOH solution.
5) 색도5) Chromaticity
색차계(Model CR-400, Minolta Co., Ltd., Tokyo., Japan)로 Hunter scale에 따라 L, a, b 값으로 표시하였다.
A, and b values according to the Hunter scale with a color difference meter (Model CR-400, Minolta Co., Ltd., Tokyo, Japan).
6) 염도6) Salinity
염도는 시료 10 g을 취해 증류수 90 mL를 가하여 충분히 혼합한 후 디지털 염도계(TM-30D, Takemura Electric works Ltd., Tokyo, Japan)를 이용하여 측정한 값에 희석배수를 곱하여 나타내었다.
The salinity was calculated by multiplying the measured value with a dilution factor by using a digital salinometer (TM-30D, Takemura Electric Works Ltd., Tokyo, Japan) after taking 10 g of the sample and adding 90 mL of distilled water.
7) 유기산 및 유리당7) Organic acid and free sugar
유기산과 유리당의 분석은 시료 5 g에 증류수 45 mL를 가하여 1시간 동안 균질화시킨 후 0.45 ㎛ 멤브레인 필터에 통과시킨 후 표 3의 분석조건으로 HPLC로 동시에 분석하였다.To analyze the organic acid and free sugar, 45 mL of distilled water was added to 5 g of the sample, homogenized for 1 hour, passed through a 0.45 μm membrane filter, and simultaneously analyzed by HPLC under the analysis conditions shown in Table 3.
8) 유리 아미노산8) free amino acids
유리 아미노산은 시료 2 g을 취하여 3차 증류수 30 mL 넣고 교반한 후 50 mL로 정용한 후 초음파를 이용하여 20분간 추출한 후 원심분리(3000 rpm, 10분)한 다음 상등액 2 mL에 5% TCA 2 mL를 넣은 후 원심분리(10,000 rpm, 10분)한 후 상등액을 취하여 0.02N-HCl로 희석한 후 0.2 ㎛ 실린지 필터에 통과시킨 후 표 4의 분석조건으로 아미노산 분석기로 분석하였다.For free amino acids, take 2 g of sample and add 30 mL of third distilled water. After stirring for 30 minutes, centrifuge (3000 rpm, 10 minutes) using ultrasound for 20 minutes, then add 2 mL of 5% TCA After centrifugation (10,000 rpm, 10 min), the supernatant was diluted with 0.02 N HCl, passed through a 0.2 μm syringe filter, and analyzed with an amino acid analyzer under the analysis conditions shown in Table 4.
Hitachi 4.6×40mm (Ammonia filtering)Hitachi 4.6 x 60 mm (speration)
Hitachi 4.6 × 40 mm (Ammonia filtering)
9) 유해 미생물9) Harmful microorganisms
고추장의 일반세균, 진균, 바실러스 세레우스 등의 식품유해균 잔존 여부는 제품의 안전성 평가에 중요 요인으로 작용하므로 최종제품의 안전성 확보를 위해 유해균의 검출 여부를 확인하였다. 세균수, 진균수(곰팡이, 효모)의 측정을 위해 시료 10 g을 멸균한 식염수에 넣어 교반한 후 희석해서 페트리 필름(3M, USA)를 이용하여 측정하였다. 식중독 미생물 분석은 식품공전법에 준하여 실험을 실시하였다.
The presence of harmful bacteria such as general bacteria, fungi, and Bacillus cereus in kochujang was an important factor in the safety evaluation of the product, so the detection of harmful bacteria was confirmed in order to secure the safety of the final product. For the measurement of bacterial counts and fungal counts (fungi, yeast), 10 g of the sample was added to sterilized saline, stirred, diluted, and measured using Petri film (3M, USA). The microbiological analysis of food poisoning was carried out according to the food revolution method.
10) 총 페놀성 화합물 함량(total phenolic content, TPC)10) Total phenolic content (TPC)
시료 1 mL에 10% Folin-ciocalteu's 페놀 시약 5 mL를 첨가하여 3분간 반응시킨 후 7.5% Na2CO3 4 mL를 첨가하였다. 이 반응액을 암소에서 반응(23℃, 1시간)시킨 후 765 nm에서 흡광도를 측정하였으며, 총 페놀성 화합물 함량은 갈산(gallic acid)을 표준물질로 하여 시료 100 g당 ㎍ gallic acid로 나타내었다.
5 mL of 10% Folin-ciocalteu's phenol reagent was added to 1 mL of the sample, reacted for 3 minutes, and then 4 mL of 7.5% Na 2 CO 3 was added. The reaction solution was reacted in a dark place (23 ° C., 1 hour) and absorbance was measured at 765 nm. The total phenolic compound content was expressed as gallic acid per 100 g of sample using gallic acid as a standard .
11) DPPH 라디칼 소거능11) DPPH radical scavenging ability
시료 0.4 mL에 100 uM DPPH 용액 1.6 mL를 첨가하여 암소에서 20분간 반응시킨 후 515 nm에서 흡광도를 측정하였으며 대조구로는 아스코르브산(ascorbic acid)을 사용하였다. DPPH 라디칼 소거능은 아래의 식으로 산출하여 나타내었다. 1.6 mL of 100 uM DPPH solution was added to 0.4 mL of the sample, reacted in a dark place for 20 minutes, and the absorbance at 515 nm was measured. As a control, ascorbic acid was used. DPPH radical scavenging activity was calculated by the following equation.
DPPH 라디칼 소거능(%) = ((대조구 흡광도 - 시료 흡광도)/대조구 흡광도) × 100
DPPH radical scavenging activity (%) = ((control absorbance - sample absorbance) / control absorbance) × 100
12) 췌장 리파아제(pancreatic lipase) 저해활성12) Pancreatic lipase inhibitory activity
리파아제 활성 측정 평판 배지는 선택배지(1% glyceryl tributyrate, 10mM CaCl2, 2% gum arabic, 200 mM NaCl, 1% agar in H2O)를 제조해 121℃에서 15분 동안 멸균한 후 페트리디쉬에 각 15 mL씩 분주하여 평판 배지를 제조하였고 지름 6 mm의 페이퍼 디스크(paper disc)를 지정된 위치에 올렸다. 췌장 리파아제(sigma, 100UN)는 0.1M Tris-HCl 완충액(pH 7.4)에 용해하여 췌장 리파아제 용액(100 unit/mL)으로 하였고, 얼음 위에 두고 사용하였다. (1% glyceryl tributyrate, 10 mM CaCl 2 , 2% gum arabic, 200 mM NaCl, 1% agar in H 2 O) was prepared and sterilized at 121 ° C for 15 minutes. Each plate was dispensed in 15 mL increments to produce a plate culture medium. A paper disc with a diameter of 6 mm was placed at the designated position. Pancreatic lipase (Sigma, 100UN) was dissolved in 0.1M Tris-HCl buffer (pH 7.4) to give pancreatic lipase solution (100 units / mL) and placed on ice.
0.1M Tris-HCl 완충액(pH 7.4) 50 ㎕, 시료액 50 ㎕, 췌장 리파아제 용액(100 unit/mL) 100 ㎕를 마이크로 튜브(micro tube)에 취하여 피펫을 이용해 혼합한 후 20 ㎕를 페이퍼 디스크(paper disc) 위에 분주하여 37℃에서 18시간 배양하였고, 투명환의 크기를 효소활성으로 하여 췌장 리파아제에 대한 저해활성을 확인하였다. 양성 대조군으로 발효액 대신 오르리스타트(1 mg/mL)를 반응시키고, 음성 대조군으로는 완충액과 반응시킨 췌장 리파아제를 분주하여 크기를 측정하고 저해활성을 아래의 식에 대입하여 산출하였다.50 μl of a 0.1 M Tris-HCl buffer (pH 7.4), 50 μl of a sample solution and 100 μl of a pancreatic lipase solution (100 units / ml) were taken in a micro tube and mixed using a pipette. paper disc, and incubated at 37 ° C for 18 hours. The inhibitory activity against pancreatic lipase was confirmed by determining the size of the transparent ring as an enzyme activity. As a positive control, orlistat (1 mg / mL) was reacted in place of the fermentation broth and pancreatic lipase, which was reacted with the buffer, was used as a negative control, and the size was measured and the inhibitory activity was calculated by substituting the following equation.
췌장 리파아제 저해 활성(%) = (1-(시료 halo 사이즈/음성 대조군 halo 사이즈) × 100
Pancreatic lipase inhibitory activity (%) = (1- (sample halo size / negative control halo size) x 100
실시예Example 1. 균주 종류에 따른 사과 유산균 발효액의 이화학적 특성 1. Physicochemical properties of fermentation broth of Lactobacillus acidophilus according to strain type
100% 사과 착즙액에 1차로 선발된 발효 균주를 접종한 후 발효 전후의 pH, 산도, 당도, 생균수를 비교한 결과는 표 5와 같다. 모든 구간에서 발효 전에 비해 발효 후 미생물의 생균수가 증가하였으며, 특히 유산균을 접종한 사과 발효액에서 발효 전 105 CFU/mL에서 발효 후 109-10 CFU/mL까지 증가하였다. 균주를 접종하지 않은 사과 착즙액의 pH 4.30, 산도 0.25%였으며, 유산균 발효액의 경우 발효로 인해 산도가 감소하였는데, 이는 발효가 진행됨에 따라 유산 발효(malolactic fermentation)에 의해 사과산의 함량이 감소하고 젖산 발효(lactic acid fermentation)가 동시에 진행됨에 따라 젖산의 함량은 증가하며, 총 산도는 감소한 것으로 판단된다.Table 5 shows the results of comparing the pH, acidity, sugar content, viable cell count before and after fermentation after inoculation of the fermentation strain selected first into 100% apple juice. The viable count of microorganisms increased after fermentation in all sections, especially in apple fermented broth inoculated with lactic acid bacteria, increased from 10 5 CFU / mL before fermentation to 10 9 - 10 CFU / mL after fermentation. The pH of the apple juice which did not inoculated with the strain was 4.30 and the acidity was 0.25%. The lactic acid fermentation broth had decreased acidity due to fermentation. As the fermentation progressed, malic acid fermentation decreased malic acid content and lactic acid As the fermentation (lactic acid fermentation) progresses simultaneously, the content of lactic acid increases and the total acidity decreases.
모든 사과 발효액 내에서 유산균이 잘 증식하는 것을 확인하였으며, 사과 발효액의 24시간 발효한 결과, 발효취 및 맛이 가장 좋다고 평가된 락토바실러스 사케이 SRCM101053 균주, 락토바실러스 사케이 SRCM101057 균주, 웨이셀라 콘퓨사 SRCM100883를 선발하여 사과 유산균 발효액을 제조하였다.It was confirmed that the lactic acid bacteria proliferated well in all apple fermentation broth. As a result of fermentation of apple fermentation broth for 24 hours, Lactobacillus sacrifice SRCM101053 strain, Lactobacillus sacrifice SRCM101057 strain, SRCM100883 was selected to prepare a fermentation broth of apple lactic acid bacteria.
시간Fermentation
time
(%)Acidity
(%)
(brix)Sugar content
(brix)
(CFU/mL)Viable cell count
(CFU / mL)
실시예Example 2. 사과 발효액 첨가량에 따른 1차 2. According to the addition amount of apple fermentation liquid, 발효물Fermentation product 및 고추장의 And red pepper paste 아미노태Amino acid 질소 함량 Nitrogen content
표 1의 사과 발효액 첨가량에 따른 1차 발효물 및 균주 종류에 따른 완성된 고추장의 발효기간에 따른 아미노태 질소 함량은 하기 표 6과 같다. 그 결과, 1차 발효물은 발효 7일 이후 아미노태 질소 함량이 100 ㎎% 이상으로 증가하였으며, 고추장의 경우 발효 7일 이후 130 ㎎%까지 증가하여 2차 발효 후 아미노태 질소 함량이 더욱 증진됨을 확인할 수 있었다. 또한, 사과 발효액을 24% 첨가하여 제조한 고추장이 가장 높은 아미노태 질소 함량을 나타내었다. 균주 중에서는 락토바실러스 사케이 SRCM101057 균주를 이용한 고추장이 아미노태 질소 함량이 가장 높게 나타났다.Table 1 shows the contents of amino nitrogen in fermentation period of the finished kochujang according to the kind of fermented product and strain according to the addition amount of the fermentation broth in Table 1. As a result, the amino acid nitrogen content of the first fermented product increased to more than 100 ㎎% after 7 days of fermentation, and increased to 130 ㎎% after 7 days of fermentation in case of kochujang, I could confirm. In addition, the highest amino nitrogen content of kochujang prepared by adding 24% of apple fermented broth was shown. Among the strains, Kochujang containing Lactobacillus sacae SRCM101057 showed the highest amino nitrogen content.
(%)Apple fermented milk content
(%)
(mg%)Amino nitrogen value
(mg%)
SRCM101053 Lb. sakei
SRCM101053
SRCM101057 Lb. sakei
SRCM101057
SRCM100883 W. confusa
SRCM100883
실시예Example 3. 고추장의 품질 분석 3. Quality Analysis of Kochujang
상기 제조예 1의 방법으로 제조된 고추장, 상기 제조예 1의 방법으로 고추장을 제조하되, (2)단계에서 사과 유산균 발효액을 첨가하지 않고 정제수 248 g을 첨가하여 제조한 고추장, 또한, 상기 제조예 1의 방법으로 고추장을 제조하되 (2)단계에서 사과 유산균 발효액을 첨가하지 않고, 사과 착즙액 248 g을 첨가하여 제조된 고추장과 균주 종류를 달리하여 제조된 고추장을 가지고 품질을 분석하였다.
The prepared kochujang prepared according to the method of Preparation Example 1 was prepared in the same manner as in Preparation Example 1 except that 248 g of purified water was added without adding the fermentation broth of the fermented liquid of the fermented lactic acid bacterium in step (2) 1). In step (2), 248 g of apple juice was added to the fermented liquor, and the quality of the fermented liquor was investigated.
1) 일반성분 분석1) General composition analysis
고추장의 일반성분 분석 결과는 표 7과 같다. 그 결과, 염도 및 색도에서는 큰 차이를 나타내지 않았고, 사과 유산균 발효액 첨가 고추장이 pH가 가장 낮고, 산도는 가장 높게 나타났다. 또한, 아미노태 질소 함량은 사과 유산균 발효액 첨가 고추장이 가장 높은 것으로 나타났으며, 균주 중에서는 락토바실러스 사케이 SRCM101057 균주를 이용한 고추장이 가장 높은 아미노태 질소 함량을 나타내었다.Table 7 shows the results of the analysis of general components of kochujang. As a result, there was no significant difference in salinity and color, and the lowest pH and the highest acidity of kochujang added with fermented liquor of apple. Amino nitrogen content of apple liquor fermentation broth was highest in kochujang. Among the strains, amino acid nitrogen content was the highest in kochujang with Lactobacillus casei SRCM101057 strain.
(%)Moisture content
(%)
(%)Titratable acidity
(%)
(mg%)AN
(mg%)
(L value)Chromaticity
(L value)
2) 유기산 및 유리당2) Organic acid and free sugar
고추장의 유기산 및 유리당 결과는 표 8 및 9와 같다. 그 결과, 대부분의 고추장이 2차 발효가 진행됨에 따라 구연산(citric acid)과 숙신산(succinic acid)의 수치가 감소하였으며, 특히, 사과 유산균 발효액 첨가 고추장은 2차 발효 전 숙신산 약 20,000 ppm에서 2차 발효 후 13,548~16,540 ppm으로 감소하였다.The results of organic acid and free sugar of kochujang are shown in Tables 8 and 9. As a result, the levels of citric acid and succinic acid decreased in most of the kochujangs as the second fermentation progressed. Especially, After fermentation, it decreased to 13,548 ~ 16,540 ppm.
유리당의 경우, 말토오스(maltose), 프락토스(fructose)는 발효 전보다 발효 후 감소하였고, 글루코스(glucose)는 오히려 증가하는 추세를 보였다.In the case of free sugar, maltose and fructose decreased after fermentation before fermentation, and glucose showed an increasing tendency.
3) 유리 아미노산3) Free amino acids
고추장의 유리 아미노산 함량 결과는 표 10과 같다. 그 결과, 사과 유산균 발효액 첨가 고추장이 사과 무첨가 고추장 및 사과 착즙액 첨가 고추장에 비해 유리 아미노산 함량이 소폭 증가하였다. 특히, 단맛을 나타내는 페닐알라닌(phenylalanine) 함량이 다른 고추장에 비해 락토바실러스 사케이 SRCM101057 균주를 이용한 고추장이 다량 증가하는 것을 확인하여, 고추장의 관능적 특성에 긍정적인 영향을 미칠 것으로 판단된다.The free amino acid content of kochujang is shown in Table 10. As a result, free amino acid content of kochujang added with fermented apple fermented milk was slightly increased compared to those without added apple kochujang and apple juice. Especially, the content of phenylalanine, which has a sweet taste, was significantly increased compared with those of other kochujang by using Lactobacillus saccharum SRCM101057, which is thought to have a positive effect on the sensory characteristics of kochujang.
4) 미생물학적 특성 분석4) Microbiological characterization
고추장의 미생물학적 특성 결과는 표 11과 같다. 고추장의 일반 세균수는 105~106 CFU/g 범위에서 나타났으며, 진균수는 102 CFU/g의 범위에서 나타났다. 식중독 미생물인 바실러스 세레우스(B. cereus)는 101~103 CFU/g에서 검출되었으며, 이는 식약청 허용기준인 104 CFU/g를 넘지 않는 수치였고, 사과 유산균 발효액 첨가 고추장이 가장 낮은 수치를 나타내었다. 그 외 식중독 미생물들은 모든 시료에서 미검출되었다.The microbiological characteristics of kochujang are shown in Table 11. The number of general bacteria in Kochujang was in the range of 10 5 to 10 6 CFU / g and the number of fungi was in the range of 10 2 CFU / g. The food poisoning microorganism is Bacillus cereus (B. cereus) is 1 to 10 were detected at 10 3 CFU / g, which was a value not more than a 10 4 CFU / g FDA limit, apple lactic acid fermentation liquor was added Kochujang the lowest Respectively. Other foodborne microorganisms were not detected in all samples.
spp. Salmonella.
spp.
ND: 검출되지 않음
ND: Not detected
실시예Example 4. 고추장의 기능성 분석 4. Functional Analysis of Kochujang
1) 총 페놀성 화합물1) total phenolic compound
고추장의 총 페놀성 화합물의 함량은 하기 표 12와 같다. 그 결과, 사과 발효액 첨가 고추장이 사과 착즙액 첨가 고추장에 비해 높은 함량을 나타내었고, 사과 발효액 중에서는 락토바실러스 사케이 SRCM101057 균주를 이용하여 발효한 사과 발효액으로 제조된 고추장이 가장 높은 함량을 나타내었다.The content of total phenolic compounds in kochujang is shown in Table 12 below. As a result, the content of kochujang added with apple fermented juice was higher than that of kochujang added with apple juice. The highest content of kochujang prepared with fermented apple fermented with lactobacillus saca SRCM101057 was shown in apple fermentation broth.
2) 항산화 활성2) Antioxidant activity
고추장 추출물을 10 mg/mL 농도에서 측정한 DPPH 라디칼 소거능의 결과는 표 13과 같다. 그 결과, 다른 고추장에 비해 락토바실러스 사케이 SRCM101057 균주를 이용한 고추장이 28.63%로 가장 높은 활성을 나타내었다.The results of DPPH radical scavenging activity measured at 10 mg / mL concentration of kochujang extract are shown in Table 13. As a result, the highest activity of Kochujang using Lactobacillus sacae SRCM101057 strain was 28.63%.
3) 항비만 활성3) Anti-obesity activity
사과 고추장의 췌장 리파아제(pancreatic lipase) 저해 활성은 사과 착즙액 첨가 고추장에 비해 사과 유산균 발효액 첨가 고추장이 더 높은 활성을 나타내어, 항비만에 더 도움을 줄 수 있을 것으로 판단된다.The inhibitory activity of pancreatic lipase in apple kochujang was higher than that of apple juice - added kochujang.
상기 실시예 1 내지 4의 결과, 사과 착즙액 내에서 잘 생육하면서, 발효 후 발효취가 우수하고 풍미 및 기호도가 증진되면서, 아미노태 질소, 아미노산 및 총 페놀성 화합물 함량이 증진되고, 항산화 활성 및 항비만 활성도 우수하여 품질이 우수한 사과 유산균 발효액 제조에 적합한 락토바실러스 사케이(Lactobacillus sakei) SRCM101057 균주를 최종 발효 균주로 선정하였고, 상기 균주를 한국미생물보존센터에 2017년 12월 08일자로 기탁하였다(기탁번호: KFCC11755P).
As a result of the above Examples 1 to 4, it was found that the amino acid nitrogen, amino acid and total phenolic compound content were improved while the fermentation was good and the flavor and the preference degree were improved while growing well in the apple juice, Lactobacillus sakei SRCM101057 strain suitable for the fermentation of apple lactic acid bacteria having excellent anti-obesity activity and excellent in quality was selected as a final fermentation strain, and the above strain was deposited at the Korean Microorganism Conservation Center on Dec. 08, 2017 Accession No .: KFCC11755P).
실시예Example 5. 사과 발효액 첨가량에 따른 고추장의 관능검사 5. Sensory evaluation of kochujang according to the amount of apple fermentation
제조예 1의 방법으로 고추장을 제조하되 사과 발효액 첨가량을 달리하여 제조한 고추장(표 1)들은 pilot scale 고추장 생산을 위한 레시피 결정을 위하여 관능평가를 실시하였다. 그 결과, 사과 발효액을 24% 첨가한 고추장이 단맛, 감칠맛에서 높은 강도를 나타내었고, 전반적 기호도가 가장 높다고 평가되었다. 따라서, 고추장의 사과 발효액 첨가 함량은 24%로 최종 결정하였다. Kochujang prepared by the method of Preparation Example 1 and prepared by varying the addition amount of the fermentation broth of apple (Table 1) were subjected to sensory evaluation for recipe determination for production of pilot scale kochujang. As a result, kochujang added with 24% of apple fermented liquid showed high intensity in sweetness and richness, and overall acceptability was evaluated to be the highest. Therefore, the content of added apple fermentation broth in kochujang was determined to be 24%.
Claims (5)
(2) 상기 (1)단계의 제조한 사과 유산균 발효액에 찹쌀가루, 밀 종곡, 소금 및 아스퍼질러스 오리재 균주를 혼합한 후 1차 발효하는 단계; 및
(3) 상기 (2)단계의 1차 발효한 발효물에 고춧가루, 조청, 꿀, 매실 농축액 및 주정을 혼합한 후 2차 발효하는 단계를 포함하여 제조하는 것을 특징으로 하는 사과 유산균 발효액을 이용한 고추장의 제조방법.(1) Inoculating Lactobacillus sakei SRCM101057 strain (accession number: KFCC11755P) to an apple juice juice and fermenting it to prepare a fermentation broth of an apple lactic acid bacterium;
(2) a step of mixing the glutinous rice flour, wheat germ, salt and Aspergillus oryzae strain fermented by the fermentation broth of the fermented fermented lactic acid bacteria prepared in the step (1), followed by primary fermentation; And
(3) mixing the fermented product of step (1) with the fermented product of step (2), and then fermenting the fermented product after mixing the red pepper powder, sweet potato, honey, ≪ / RTI >
(1) 사과를 착즙한 착즙액에 락토바실러스 사케이(Lactobacillus sakei) SRCM101057 균주(기탁번호: KFCC11755P)를 접종한 후 발효하여 사과 유산균 발효액을 제조하는 단계;
(2) 상기 (1)단계의 제조한 사과 유산균 발효액 220~280 g에 찹쌀가루 100~140 g, 밀 종곡 90~130 g, 소금 60~80 g 및 아스퍼질러스 오리재 균주 1~3 g을 혼합한 후 1차 발효하는 단계; 및
(3) 상기 (2)단계의 1차 발효한 발효물에 고춧가루 170~200 g, 조청 180~220 g, 꿀 27~33 g, 매실 농축액 4~6 g 및 주정 27~33 g을 혼합한 후 2차 발효하는 단계를 포함하여 제조하는 것을 특징으로 하는 사과 유산균 발효액을 이용한 고추장의 제조방법.The method according to claim 1,
(1) Inoculating Lactobacillus sakei SRCM101057 strain (accession number: KFCC11755P) to an apple juice juice and fermenting it to prepare a fermentation broth of an apple lactic acid bacterium;
(2) 100 to 140 g of glutinous rice flour, 90 to 130 g of wheat germ, 60 to 80 g of salt, and 1 to 3 g of Aspergillus oryzae strain were added to 220 to 280 g of the fermentation broth of the prepared fermented lactic acid bacterium of step (1) Mixing and then primary fermenting; And
(3) 170 to 200 g of red pepper powder, 180 to 220 g of starch, 27 to 33 g of honey, 4 to 6 g of a plum concentrate and 27 to 33 g of a fermented product were mixed with the first fermented fermented product of the step (2) Wherein the fermentation broth is fermented in a fermentation broth.
(1) 사과를 착즙한 착즙액에 락토바실러스 사케이(Lactobacillus sakei) SRCM101057 균주(기탁번호: KFCC11755P) 0.8~1.2%(v/v)를 접종한 후 28~32℃에서 20~28시간 동안 발효하여 사과 유산균 발효액을 제조하는 단계;
(2) 상기 (1)단계의 제조한 사과 유산균 발효액 220~280 g에 찹쌀가루 100~140 g, 밀 종곡 90~130 g, 소금 60~80 g 및 아스퍼질러스 오리재 균주 1~3 g을 혼합한 후 28~32℃에서 6~8일 동안 1차 발효하는 단계; 및
(3) 상기 (2)단계의 1차 발효한 발효물에 고춧가루 170~200 g, 조청 180~220 g, 꿀 27~33 g, 매실 농축액 4~6 g 및 주정 27~33 g을 혼합한 후 28~32℃에서 6~8일 동안 2차 발효하는 단계를 포함하여 제조하는 것을 특징으로 하는 사과 유산균 발효액을 이용한 고추장의 제조방법.The method of claim 3,
(1) After inoculating 0.8-1.2% (v / v) of Lactobacillus sakei SRCM101057 strain (accession number: KFCC11755P) into the juice of the apple juice, fermentation was carried out at 28-32 ° C for 20-28 hours Preparing a fermentation broth of an apple lactic acid bacterium;
(2) 100 to 140 g of glutinous rice flour, 90 to 130 g of wheat germ, 60 to 80 g of salt, and 1 to 3 g of Aspergillus oryzae strain were added to 220 to 280 g of the fermentation broth of the prepared fermented lactic acid bacterium of step (1) Followed by primary fermentation at 28-32 ° C for 6-8 days; And
(3) 170 to 200 g of red pepper powder, 180 to 220 g of starch, 27 to 33 g of honey, 4 to 6 g of a plum concentrate and 27 to 33 g of a fermented product were mixed with the first fermented fermented product of the step (2) And fermenting the mixture at 28 to 32 ° C for 6 to 8 days. The method of manufacturing a kochujang using the fermentation broth of the fermented lactic acid bacteria of the present invention.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170167940 | 2017-12-08 | ||
KR20170167940 | 2017-12-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20190068462A KR20190068462A (en) | 2019-06-18 |
KR101994175B1 true KR101994175B1 (en) | 2019-07-01 |
Family
ID=67103363
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180156593A KR101994175B1 (en) | 2017-12-08 | 2018-12-07 | Method for producing red pepper paste using apple lactic acid bacteria fermented solution |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101994175B1 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000001324A (en) * | 1998-06-10 | 2000-01-15 | 김동욱 | Red pepper paste using fruit juice and making method thereof |
KR101105733B1 (en) * | 2010-01-28 | 2012-01-17 | 우재성 | Manufacturing method of vinegared red pepper paste using lactic acid bacteria |
KR101356214B1 (en) * | 2012-04-06 | 2014-01-27 | 씨제이제일제당 (주) | Koji for Gochujang having high enzymatic activity, Gochujang using the koji, and methods thereof |
-
2018
- 2018-12-07 KR KR1020180156593A patent/KR101994175B1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR20190068462A (en) | 2019-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101814420B1 (en) | Method for producing mixed Chunggukjang and Doenjang using Bacillus subtilis SY07 strain and mixed Chunggukjang and Doenjang produced by the same method | |
KR20120125042A (en) | A process for preparing a fermented broth of herbal medicine by combined microorganisms, a fermented broth prepared by the process, and a fermented food prepared by the fermented broth | |
KR101793933B1 (en) | Functional Gochujang Having Antioxidant Activity and Whitening Effects and Manufacturing Method Thereof | |
KR101859929B1 (en) | Wine and vinegar with high taste and flavor and functionality from mixtures of kiwi-fruit, persimmon and wild grapes, and preparation method thereof | |
KR101616187B1 (en) | Method for manufacturing fermented beverage with Schisandra chinensis using GABA producing Lactobacillus | |
KR102376622B1 (en) | Lactobacillus pentosus SRCM209254 strain having anti-inflammatory and antioxidant activity and uses thereof | |
KR20170114112A (en) | Bacillus subtilis strain SY07 isolated from traditionally fermented soybean product and uses thereof | |
KR101399276B1 (en) | Method for producing short-ripened soy sauce and short-ripened soy sauce produced by same method | |
KR102133721B1 (en) | functional food composition for antioxidant effect comprising fermented permission leaf | |
KR101693315B1 (en) | Method for producing barley soybean paste using functional strain and barley soybean paste produced by the same method | |
KR101157545B1 (en) | Fermentable wine comprising Chinese medicine and manufacturing method thereof | |
KR101994175B1 (en) | Method for producing red pepper paste using apple lactic acid bacteria fermented solution | |
KR101840733B1 (en) | Method for producing Doenjang dressing sauce and Doenjang dressing sauce produced by the same method | |
KR20190068461A (en) | Apple fermented beverage using Weissella confusa SRCM100892 strain and method for producing jelly using the same | |
KR100577457B1 (en) | Fermented Herb Wine and Method of Preparing the Same | |
KR20200097428A (en) | Grain fermented beverage using compound grain fermentation agent and fermented lactic acid bacteria and method of production thereof | |
KR101821749B1 (en) | Method for producing hot pepper paste sauce using licorice Jocheong | |
KR101903633B1 (en) | Method for producing fermented Allium hookeri using blueberry solution fermented by lactic acid bacteria | |
KR20190083623A (en) | Chungkookjang, preparation method thereof and a sauce composition for Cheonggukjang stew containing the same | |
KR101940277B1 (en) | Method for producing barley red pepper paste using functional microorganism and barley red pepper paste produced by the same method | |
KR100580334B1 (en) | Food composition improved in taste and preservation ability by comprising lentinus edodes extract obtained by treatment of enzyme in low temperature | |
KR101553380B1 (en) | Method for producing Kochujang using fermented tomato product and functional properties | |
KR102189342B1 (en) | Bacillus subtilis SRCM103716 strain having excellent β-glucosidase and antioxidant activity and uses thereof | |
KR20220025678A (en) | Method for producing fermented barley sprout postbiotics with increased effective component content using lactic acid bacteria | |
Kim et al. | Quality characteristics of kochujang prepared with different meju fermented with Aspergillus sp. and Bacillus subtilis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |